title: The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice.
abstract: Age-associated loss of muscle mass, or sarcopenia, contributes directly to frailty and an increased risk of falls and fractures among the elderly. Aged mice and elderly adults both show decreased muscle mass as well as relatively low levels of the fat-derived hormone leptin. Here we demonstrate that loss of muscle mass and myofiber size with aging in mice is associated with significant changes in the expression of specific miRNAs. Aging altered the expression of 57 miRNAs in mouse skeletal muscle, and many of these miRNAs are now reported to be associated specifically with age-related muscle atrophy. These include miR-221, previously identified in studies of myogenesis and muscle development as playing a role in the proliferation and terminal differentiation of myogenic precursors. We also treated aged mice with recombinant leptin, to determine whether leptin therapy could improve muscle mass and alter the miRNA expression profile of aging skeletal muscle. Leptin treatment significantly increased hindlimb muscle mass and extensor digitorum longus fiber size in aged mice. Furthermore, the expression of 37 miRNAs was altered in muscles of leptin-treated mice. In particular, leptin treatment increased the expression of miR-31 and miR-223, miRNAs known to be elevated during muscle regeneration and repair. These findings suggest that aging in skeletal muscle is associated with marked changes in the expression of specific miRNAs, and that nutrient-related hormones such as leptin may be able to reverse muscle atrophy and alter the expression of atrophy-related miRNAs in aging skeletal muscle.
authors.affiliation: Department of Cellular Biology and Anatomy, Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, GA 30912, USA. mhamrick@mail.mcg.edu
authors.forename: Mark W
authors.initials: MW
authors.lastname: Hamrick
authors.forename: Samuel
authors.initials: S
authors.lastname: Herberg
authors.forename: Phonepasong
authors.initials: P
authors.lastname: Arounleut
authors.forename: Hong-Zhi
authors.initials: HZ
authors.lastname: He
authors.forename: Austin
authors.initials: A
authors.lastname: Shiver
authors.forename: Rui-Qun
authors.initials: RQ
authors.lastname: Qi
authors.forename: Li
authors.initials: L
authors.lastname: Zhou
authors.forename: Carlos M
authors.initials: CM
authors.lastname: Isales
authors.forename: Qing-Sheng
authors.initials: QS
authors.lastname: Mi
mesh_terms: D000375:Aging / Q000187:drug effects* / Q000235:genetics / Q000473:pathology; D000818:Animals; D020869:Gene Expression Profiling; D020738:Leptin / Q000627:therapeutic use*; D051379:Mice; D008810:Mice, Inbred C57BL; D035683:MicroRNAs / Q000235:genetics*; D024510:Muscle Development / Q000187:drug effects* / Q000235:genetics; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000473:pathology; D009133:Muscular Atrophy / Q000188:drug therapy*
chemical_list: D020738:Leptin; D035683:MicroRNAs
references.citation: Int J Obes Relat Metab Disord. 2000 Aug;24(8):1040-50
references.pmid: 10951544
references.citation: Am J Physiol Endocrinol Metab. 2008 May;294(5):E918-27
references.pmid: 18334608
references.citation: Mech Ageing Dev. 2003 Mar;124(3):287-99
references.pmid: 12663126
references.citation: J Bone Miner Res. 2008 Jul;23(7):1118-28
references.pmid: 18435580
references.citation: J Cell Sci. 2009 Jan 1;122(Pt 1):13-20
references.pmid: 19092056
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17016-21
references.pmid: 17942673
references.citation: Cell. 2006 Mar 10;124(5):877-81
references.pmid: 16530032
references.citation: Diabetes. 2009 May;58(5):1050-7
references.pmid: 19188425
references.citation: Biochem Biophys Res Commun. 2008 Jan 25;365(4):863-9
references.pmid: 18047832
references.citation: Endocr J. 2008 Mar;55(1):11-21
references.pmid: 17878607
references.citation: Aging Cell. 2006 Jun;5(3):213-24
references.pmid: 16842494
references.citation: J Cell Mol Med. 2010 Oct;14(10):2495-505
references.pmid: 19754672
references.citation: Nature. 1998 Jun 18;393(6686):684-8
references.pmid: 9641678
references.citation: J Bone Miner Res. 2005 Nov;20(11):1921-8
references.pmid: 16234964
references.citation: PLoS One. 2009 Oct 27;4(10):e7607
references.pmid: 19859555
references.citation: Eur J Endocrinol. 2000 Jan;142(1):25-9
references.pmid: 10633217
references.citation: Bone. 2004 Mar;34(3):376-83
references.pmid: 15003785
references.citation: FASEB J. 2009 Oct;23(10):3335-46
references.pmid: 19528256
references.citation: Diabetologia. 2002 Jul;45(7):997-1003
references.pmid: 12136398
references.citation: BMJ. 2008 Jan 19;336(7636):124-6
references.pmid: 18202065
references.citation: J Appl Physiol (1985). 2007 May;102(5):1786-92
references.pmid: 17234799
references.citation: J Am Geriatr Soc. 2008 Feb;56(2):279-84
references.pmid: 18179487
references.citation: Bone. 2006 Oct;39(4):845-53
references.pmid: 16750436
references.citation: Physiol Genomics. 2007 Nov 14;31(3):510-20
references.pmid: 17804603
references.citation: J Bone Miner Res. 2004 Oct;19(10):1607-11
references.pmid: 15355554
references.citation: Int J Obes Relat Metab Disord. 2002 Nov;26(11):1407-33
references.pmid: 12439643
references.citation: PLoS One. 2009;4(5):e5605
references.pmid: 19440384
references.citation: Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1333-40
references.pmid: 18827171
references.citation: J Clin Endocrinol Metab. 1998 May;83(5):1407-13
references.pmid: 9589630
references.citation: Trends Genet. 2008 Apr;24(4):159-66
references.pmid: 18325627
references.citation: J Biol Chem. 2009 Jul 17;284(29):19679-93
references.pmid: 19439412
references.citation: J Cell Mol Med. 2009 Apr;13(4):606-18
references.pmid: 19220576
references.citation: Cell Transplant. 2009;18(9):1039-45
references.pmid: 19523330
references.citation: Nature. 2005 Jun 16;435(7044):974-8
references.pmid: 15944714
references.citation: PLoS One. 2009 Sep 04;4(9):e6808
references.pmid: 19730740